Back to top
more

Tilray Brands (TLRY)

(Delayed Data from NSDQ)

$1.73 USD

1.73
23,566,321

-0.13 (-6.99%)

Updated Aug 5, 2024 04:00 PM ET

After-Market: $1.74 +0.01 (0.58%) 7:12 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 25% (187 out of 251)

Industry: Consumer Products - Staples

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

The Zacks Analyst Blog Highlights: Constellation Brand, Canopy Growth, Aurora Cannabis, Cronos and Tilray

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Constellation Brand, Canopy Growth, Aurora Cannabis, Cronos and Tilray

Daniel Laboe headshot

Constellation Makes Big Cannabis Bet

by Daniel Laboe

Constellation Brands have been continuously adding to their stake in Canopy Growth (CGC), which is the leading player in the Canadian cannabis market. STZ just added another $4 billion investment in August bringing its total stake in Canopy to 38% ownership.

Neena Mishra headshot

Best Performing ETFs of the First Quarter

by Neena Mishra

Major indexes posted their best quarterly performance since the financial crisis; here are some ETFs that soared during the quarter

Sweta Killa headshot

Short Sellers and Easing Rules Boost Pot ETF Higher

by Sweta Killa

Along with easing rules, short-selling of the stocks led to the spike in the pot ETF.

Nalak Das headshot

US Marijuana Industry to Flourish in 2019: Who Gains?

by Nalak Das

Legalization has long been considered a boon for the marijuana industry.

Sanghamitra Saha headshot

Tilray Earnings Impressive: More Reasons to Buy Marijuana ETFs

by Sanghamitra Saha

Tilray earnings results speak of bullishness, making things better for marijuana ETF investors.

Tilray, Inc. (TLRY) Flat As Market Gains: What You Should Know

by Zacks Equity Research

Tilray, Inc. (TLRY) closed at $70 in the latest trading session, marking no change from the prior day.

Athersys (ATHX) Q4 Earnings: What's in Store for the Stock?

by Zacks Equity Research

During Athersys' (ATHX) Q4 conference call, investor focus will be on the company's progress with its investigational MultiStem cell therapy to treat various indications.

Is a Beat in Store for Catabasis (CATB) This Earnings Season?

by Zacks Equity Research

Catabasis (CATB) progresses with DMD candidate, edasalonexent. However, operating expenses are likely to be lower.

What's in Store for BioSpecifics (BSTC) This Earnings Season?

by Zacks Equity Research

BioSpecifics (BSTC) is expected to provide updates on Xiaflex and its pipeline candidates in its fourth quarter earnings call.

What's in the Cards for Corbus (CRBP) This Earnings Season?

by Zacks Equity Research

Corbus (CRBP) is expected to provide updates on its pipeline candidates in the fourth quarter conference call.

Champions Oncology (CSBR) Q3 Earnings: What's in Store?

by Zacks Equity Research

During Champions Oncology's (CSBR) third-quarter fiscal 2019 conference call, investor focus will be on the company's progress with its Ex Vivo platform and services.

What's in the Cards for Novavax (NVAX) This Earnings Season?

by Zacks Equity Research

Novavax (NVAX) is expected to provide updates on its lead vaccine candidate, Resvax when it reports fourth-quarter 2018 results.

Sanghamitra Saha headshot

Why Marijuana ETFs & Stocks Have More Room to Run

by Sanghamitra Saha

Marijuana stocks and ETFs are hot this year and can perform better in the coming days.

Cronos (CRON) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

Investors will focus on regular top and bottom-line numbers along with pipeline progress when Cronos (CRON) reports fourth-quarter results.

Sanghamitra Saha headshot

Top Performing ETF Areas of February

by Sanghamitra Saha

Let's take look at the top ETF areas of February 2019.

Options Traders Expect Huge Moves in Tilray (TLRY) Stock

by Zacks Equity Research

Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.

Tilray, Inc. (TLRY) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, Tilray, Inc. (TLRY) closed at $79.07, marking a -0.16% move from the previous day.

Neena Mishra headshot

Marijuana Stocks and ETFs: Risks and Rewards

by Neena Mishra

Pot stocks are soaring again. To learn more about risks and rewards of investing in marijuana stocks and ETFs, check out this Exploring ETFs video.

Benjamin Rains headshot

What Investors Need to Know About Investing in Marijuana Stocks

by Benjamin Rains

Let's look at what investors need to know about the marijuana industry and how to invest in the future of pot.

Sweta Killa headshot

Tilray's Deal to Buy Hemp Food Maker Bolsters Marijuana ETF

by Sweta Killa

Tilray's deal to acquire the hemp food maker Manitoba Harvest has bolstered the outlook of the already high-flying marijuana ETF.

Tilray, Inc. (TLRY) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Tilray, Inc. (TLRY) closed at $76.49 in the latest trading session, marking a -0.17% move from the prior day.

Sanghamitra Saha headshot

4 Reasons Why Marijuana Stocks & ETFs Could Be on a High in 2019

by Sanghamitra Saha

Marijuana stocks and related ETFs caught investors' attention last year, courtesy of its mysterious rally in mid-2018 on Canada's legalization of recreational marijuana in October. Let's take a look at whether the space will be able to maintain its rally in 2019.

Tracey Ryniec headshot

Pot Stocks: Who Has the Best Earnings Chart?

by Tracey Ryniec

Pot stocks are entering the investing mainstream but do they have what it takes to compete against mature industries?

Tilray, Inc. (TLRY) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Tilray, Inc. (TLRY) closed at $79.24 in the latest trading session, marking a -0.94% move from the prior day.